EMAIL THIS PAGE TO A FRIEND

PloS one

Arsenic trioxide sensitizes glioblastoma to a myc inhibitor.


PMID 26038891

Abstract

Glioblastoma multiforme (GBM) is associated with high mortality due to infiltrative growth and recurrence. Median survival of the patients is less than 15 months, increasing requirements for new therapies. We found that both arsenic trioxide and 10058F4, an inhibitor of Myc, induced differentiation of cancer stem-like cells (CSC) of GBM and that arsenic trioxide drastically enhanced the anti-proliferative effect of 10058F4 but not apoptotic effects. EGFR-driven genetically engineered GBM mouse model showed that this cooperative effect is higher in EGFRvIII-expressing INK4a/Arf-/- neural stem cells (NSCs) than in control wild type NSCs. In addition, treatment of GBM CSC xenografts with arsenic trioxide and 10058F4 resulted in significant decrease in tumor growth and increased differentiation with concomitant decrease of proneural and mesenchymal GBM CSCs in vivo. Our study was the first to evaluate arsenic trioxide and 10058F4 interaction in GBM CSC differentiation and to assess new opportunities for arsenic trioxide and 10058F4 combination as a promising approach for future differentiation therapy of GBM.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

F3680
10058-F4, ≥98% (HPLC), solid
C12H11NOS2
HPA007007
Anti-NES antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA026111
Anti-NES antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2104575
Anti-NES antibody produced in rabbit, affinity isolated antibody
SAB4200394
Anti-Nestin (C-terminal) antibody produced in rabbit, ~1.5 mg/mL, affinity isolated antibody
AV32753
Anti-OLIG2 (AB1) antibody produced in rabbit, affinity isolated antibody
AV31464
Anti-OLIG2 (AB2) antibody produced in rabbit, affinity isolated antibody
AV32752
Anti-OLIG2 (AB3) antibody produced in rabbit, affinity isolated antibody
SAB1412293
ANTI-OLIG2 antibody produced in mouse, clone 2A8, purified immunoglobulin, buffered aqueous solution
SAB1412294
ANTI-OLIG2 antibody produced in mouse, clone 2B11, purified immunoglobulin, buffered aqueous solution
HPA003254
Anti-OLIG2 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SRP4038 Fgf-2 from mouse, recombinant, expressed in E. coli, ≥95% (SDS-PAGE), ≥95% (HPLC)
SRP4039 Fgf-2 from rat, recombinant, expressed in E. coli, ≥97% (SDS-PAGE), ≥97% (HPLC)
SRP4037 FGF-2 human, recombinant, expressed in E. coli, ≥95% (SDS-PAGE), ≥95% (HPLC)
SRP2092
FGF-2 human, recombinant, expressed in insect cells, ≥85% (SDS-PAGE)
WH0010215M2
Monoclonal Anti-OLIG2 antibody produced in mouse, clone 3D7, purified immunoglobulin, buffered aqueous solution
SAB1404798
Monoclonal Anti-OLIG2 antibody produced in mouse, clone 3C9, purified immunoglobulin, buffered aqueous solution
SAB5300407
Monoclonal Anti-OLIG2 antibody produced in mouse, clone 1G11, ascites fluid